(Total Views: 489)
Posted On: 08/27/2021 9:21:07 AM
Post# of 30067
I see you recently hinted $ADTX as the potential partner for the Covid-19 related spin off. Yesterday ADTX announced raising $10.1 million and intend to fund a $6.5M loan to a biopharmaceutical company commercializing COVID-19 antiviral oral therapy.
On Aug 25, they announced:
Key terms of the proposed transaction as stated in the LOI include: the completion of a proposed $6.5M secured loan from Aditxt to the Target Company by August 31, 2021, as well as Aditxt issuing such number of shares of common stock that yields 50% of the number of Aditxt’s outstanding shares post-closing of the transaction.
On Aug 25, they announced:
Key terms of the proposed transaction as stated in the LOI include: the completion of a proposed $6.5M secured loan from Aditxt to the Target Company by August 31, 2021, as well as Aditxt issuing such number of shares of common stock that yields 50% of the number of Aditxt’s outstanding shares post-closing of the transaction.
(2)
(0)
